Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant

Journal of Clinical Investigation

Volumn 98, Issue 4, 1996, Pages 1034-1046

  Ku, Nam On ^a,c   Michie, Sara A ^a   Soetikno, Roy M ^a,c   Resurreccion, Evelyn Z ^a   Broome, Rosemary L ^a   Oshima, Robert G ^b   Omary, M Bishr ^a,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b BURNHAM INSTITUTE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acetaminophen; glycosylation; griseofulvin; liver; phosphorylation

Indexed keywords

GRISEOFULVIN; KERATIN; KERATIN 18; PARACETAMOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE DISRUPTION; HISTOPATHOLOGY; INTERMEDIATE FILAMENT; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION;

EID: 0029789008     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118864     Document Type: Article

References (53)

1. Moll, R., W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 31:11-24.
2. Steinert, P.M., and D.R. Roop. 1988. Molecular and cellular biology of intermediate filaments. Ann. Rev. Biochem. 57:593-625.
3. Fuchs, E., and Weber, K. 1994. Intermediate filaments: structure, dynamics, function and disease. Annu. Rev. Biochem. 63:345-382.
4. Fuchs, E., and P.A. Coulombe. 1992. Of mice and men: genetic skin diseases of keratin. Cell. 69:899-902.
5. Steinert, P.M., and S.J. Bale. 1993. Genetic skin diseases caused by mutations in keratin intermediate filaments. Trends Genet. 9:280-284.
6. Fuchs, E., Y-M. Chan, A.S. Paller, and Q-C. Yu. 1994. Cracks in the foundation: keratin filaments and genetic disease. Trends Cell Biol. 4:321-326.
7. McLean, W.H.I., and E.B. Lane. 1995. Intermediate filaments in disease. Curr. Opin. Cell Biol. 7:118-125.
8. McLean, W.H.I., E.L. Rugg, D.P. Lunny, S.M. Morley, E.B. Lane, O. Swensson, P.J.C. Dopping-Hepenstal, W.A.D. Griffiths, R.A.J. Eady, C. Higgins, H.A. Navsaria, I.M. Leigh, T. Strachan, L. Kunkeler, and C.S. Munro. 1995. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nature Genet. 9:273-278.
9. Bowden, P.E., J.L. Haley, A. Kansky, J.A. Rothnagel, D.O. Jones, and R.J. Turner. 1995. Mutation of a type II keralin gene (K6a) in pachyonychia congenita. Nature Genet. 10:363-365.
10. Rugg, E.L., W.H.I. McLean, W.E. Allison, D.P. Lunny, R.I. Macleod, D.J. Felix, E.B. Lane, and C.S. Munro. 1995. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nature Genet. 11:450-452.
11. Richard, G., V. De Laurenzi, B. Didona, S.J. Bale, and J.G. Compton. 1995. Keratin 13 point mutation underlies the hereditary mucosal epithelia disorder white sponge nevus. Nature Genet. 11:453-455.
12. Figlewicz, D.A., A. Krizus, M.G. Martinoli, V. Meininger, M. Dib, G.A. Rouleau, and J.-P. Julien. 1994. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerrosis. Hum. Mol. Genet. 3:1757-1761.
13. Vassar, R., P.A. Coulombe, L. Degenstein, K. Albers, and E. Fuchs. 1991. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 64:365-380.
14. Coulombe, P.A., M.E. Hutton, A. Letai, A. Hebert, A.S. Paller, and E. Fuchs. 1991. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analysis. Cell. 66:1301-1311.
15. Baribault, H., R. Price, K. Miyai, and R.G. Oshima. 1993. Mid-gestational lethality in mice lacking keratin 8. Genes & Dev. 7:1191-1202.
16. Baribault, H., J. Penner, R.V. Iozzo, and M. Wilson-Heiner. 1994. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes & Dev. 8:2964-2973.
17. Blessing, M., U. Ruther, and W.W. Franke. 1993. Ectopic synthesis of epidermal cytokeratins in pancreatic islet cells of transgenic mice interferes with cytoskeletal order and insulin production. J. Cell Biol. 120:743-755.
18. Albers, K.M., F.E. Davis, T.N. Perrone, E.Y. Lee, Y. Liu, and M. Vore. 1995. Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities. J. Cell Biol. 128:157-169.
19. Ku, N-O., S. Michie, R.G. Oshima, and M.B. Omary. 1995. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell Biol. 131: 1303-1314.
20. Abe, M., and R.G. Oshima. 1990. A single human keratin 18 gene is expressed in diverse epithelial cells of transgenic mice. J. Cell Biol. 111:1197-1206.
21. Liao, J., L.A. Lowthert, and M.B. Omary. 1995. Heat stress or rotavirus infection of human epithelial cells generates a distinct hyperphosphorylated form of keratin 8. Exp. Cell Res. 219:348-357.
22. Chou, C-F., and M.B. Omary. 1993. Mitotic-arrest associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J. Biol. Chem. 268:4465-4472.
23. Chou, C-F., and M.B. Omary. 1994. Mitotic arrest with anti-microtubule agents or okadaic acid is associated with increased glycoprotein terminal GlcNAc's. J. Cell Sci. 107:1833-1843.
24. Liao, J., L.A. Lowthert, N-O. Ku, R. Fernandez, and M.B. Omary. 1995. Dynamics of human keratin 18 phosphorylation: polarized distribution of phosphorylated keratins in simple epithelial tissues. J. Cell Biol. 131:1291-1301.
25. Mallory, F.B. 1911. Cirrhosis of the liver. Five different types of lesions from which it may arise. Bull. Johns Hopkins Hosp. 22:69-75.
26. Denk, H., F. Gschnait, and K. Wolff. 1975. Hepatocellular hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Lab. Invest. 32:773-776.
27. Barich, L.L., J. Schwarz, D.J. Barich, and M.G. Horowitz. 1961. Toxic liver damage in mice after prolonged intake of elevated doses of griseofulvin. Antibiot. Chemother. 11:566-571.
28. Weston Hurst, E., and G.E. Paget. 1963. Protoporphyrin, cirrhosis and hepatomata in the livers of mice given griseofulvin. Br. J. Dermatol. 75:105-112.
29. Salmhofer, H., I. Rainer, K. Zatloukal, and H. Denk. 1994. Post-translational events involved in griseofulvin-induced keratin cytoskeleton alterations. Hepatology. 20:731-740.
30. Cadrin, M., N. McFarlane Anderson, L.H. Aasheim, H. Kawahara, D.J. Franks, and S.W. French. 1995. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab. Invest. 72:453-460.
31. Kaplowitz, N. Drug metabolism and hepatotoxicity. 1992. In Liver and Biliary Diseases. N. Kaplowitz, editor. Williams and Wilkins, Baltimore, MD.
32. Farrell, GC. 1994. Drug-induced Liver Disease. Churchill Livingstone, Edinburgh, Scotland.
33. Zimmerman, HJ. Hepatotoxicity. 1993. Disease-A-Month 39:675-787.
34. Lee, W.M. Drug-induced hepatotoxicity. 1995. N. Engl. J. Med. 17: 1118-1127.
35. Chou, C-F., A.J. Smith, and M.B. Omary. 1992. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18. J. Biol. Chem. 267:3901-3906.
36. Bray, G.P., J.M. Tredger, and R. Williams. 1992. S-Adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. Hepatology. 15:297-301.
37. Yokoyama, H.O., M.E. Wilson, K.K. Tsuboi, and R.E. Stowell. 1953. Regeneration of mouse liver after partial hepatectomy. Cancer Res. 13:80-85.
38. Theocharis, S.E., A.S. Skopelitou, A.P. Margeli, K.J. Pavlaki, and C. Kittas. 1994. Proliferating cell nuclear antigen (PCNA) expression in regenerating rat liver after partial hepatectomy. Dig. Dis. Sci. 39:245-252.
39. Lowthert, L.A., N-O. Ku, J. Liao, P.A. Coulombe, and M.B. Omary. 1995. Empigen BB: a useful detergent for solubilization and biochemical analysis of keratins. Biochem. Biophys. Res. Comm. 206:370-379.
40. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
41. Ku, N-O., and M.B. Omary. 1995. Identification and mutational analysis of the glycosylation sites of human keratin 18. J. Biol. Chem. 270:11820-11827.
42. Steer, C.J. 1995. Liver regeneration. FASEB J. 9:1396-1400.
43. Higgins, G.M., and R.M. Anderson. 1931. Experimental pathology of the liver. Arch. Path. 12:186-202.
44. Wilson, M.E., R.E. Stowell, H.O. Yokoyama, and K.K. Tsuboi. 1953. Cytological changes in regenerating mouse liver. Cancer Res. 13:86-92.
45. Ku, N-O., and M.B. Omary. 1994. Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorsanization. J. Cell Biol. 127:161-171.
46. Chan, Y.-M., Q.-C Yu, J.-D Fine, and E. Fuchs. 1993. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. USA. 90:7414-7418.
47. Morley, S.M., S.R. Dundas, J.L. James, T. Gupta, R.A. Brown, C.J. Sexton, H.A. Navsaria, I.M. Leigh, and E.B. Lane. 1995. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J. Cell Sci. 108:3463-3471.
48. Arnaiz, S.L., S. Llesuy, J.C. Cutrin, and A. Boveris. 1995. Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic. Biol. Med. 19:303-310.
49. Denk, H., R. Eckerstorfer, R.E. Talcott, and J.B. Schenkman. 1977. Alteration of hepatic microsomal enzymes by griseofulvin treatment of mice. Biochem. Pharmacol. 26:1125-1130.
50. 10 and α-tocopherol. Free Radic. Biol. Med. 19:169-176.
51. Ku, N-O., J. Liao, C-F. Chou, and M.B. Omary. 1996. Implications of intermediate filament protein phosphorylation. Cancer & Metastasis Rev. In press.
52. Haltiwanger, R.W., W.G. Kelly, E.P. Roquemore, M.A. Blomberg, L.-Y.D. Dong, L. Kreppel, T.-Y. Chou, and G.W. Hart. 1992. Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic. Biochem. Soc. Trans. 20: 264-269.
53. Hart, G.W., K.D. Greis, L.-Y D. Dong, M.A. Blomberg, T-Y Chou, M-S. Jiang, E.P. Roquemore, D.M. Snow, L.K. Kreppel, R.N. Cole, F.I. Comer, C.S. Arnold, and B.K. Hayes. 1995. O-Linked N-acetylglucosamine: the "Yin-Yang" of ser/thr phosphorylation? Adv. Exp. Med. Biol. 376:115-123.